SPBC557.02c Antibody

What is SPBC557.02c and what experimental systems is this antibody designed for?

SPBC557.02c is a protein encoded in Schizosaccharomyces pombe (strain 972 / ATCC 24843), commonly known as fission yeast. The antibody against this protein targets the recombinant SPBC557.02c protein (UniProt accession: Q9USS4) and is specifically designed for S. pombe research applications. This polyclonal antibody is raised in rabbits and purified using antigen affinity methods to ensure target specificity within the fission yeast experimental system .

The experimental reactivity is limited to S. pombe strain 972, so researchers should not expect cross-reactivity with other yeast species or model organisms without empirical validation. When designing experiments, it's important to consider this species specificity, particularly if conducting comparative studies across multiple model systems.

What validated applications are available for SPBC557.02c antibody?

The SPBC557.02c antibody has been validated for two primary applications:

For Western blotting applications, the antibody enables identification of the target antigen . Researchers should conduct preliminary titration experiments to determine optimal antibody concentration for their specific experimental conditions, as protein expression levels can vary significantly based on growth conditions and genetic backgrounds.

What are the recommended storage and handling protocols for maintaining antibody activity?

To preserve antibody function and prevent activity loss, researchers should adhere to these evidence-based storage protocols:

• Upon receipt, store at -20°C or -80°C as specified by the manufacturer

• Avoid repeated freeze-thaw cycles which can lead to protein denaturation and epitope degradation

• Consider preparing small working aliquots during initial thaw to minimize freeze-thaw events

• When actively using the antibody, keep on ice to slow degradation processes

• The SPBC557.02c antibody is supplied in a storage buffer containing 50% glycerol and 0.01M PBS (pH 7.4) with 0.03% Proclin 300 as a preservative

Research indicates that antibodies stored according to these protocols maintain > 90% of their activity for at least 12 months, though periodic validation with positive controls is recommended for long-term studies.

How can researchers validate the specificity of SPBC557.02c antibody in their experimental system?

Antibody validation is critical for ensuring experimental reproducibility. For SPBC557.02c antibody, implement this multi-step validation protocol:

• Positive and negative controls: Run Western blots with:

  • Purified recombinant SPBC557.02c protein (positive control)

  • Lysates from SPBC557.02c knockout strains (negative control)

  • Wild-type S. pombe lysates (experimental sample)

• Epitope competition assay: Pre-incubate the antibody with excess purified recombinant SPBC557.02c protein before Western blotting. Signal reduction indicates specific binding.

• Immunoprecipitation-Mass Spectrometry: Conduct pull-down experiments followed by mass spectrometry to confirm the identity of captured proteins matches SPBC557.02c.

• Signal correlation: Compare protein expression patterns with transcriptional data (RT-qPCR) under various conditions to confirm concordance.

This rigorous validation approach ensures that experimental findings truly reflect SPBC557.02c biology rather than non-specific interactions or technical artifacts.

What methodological considerations are essential for quantitative analysis of SPBC557.02c expression?

For accurate quantitative analysis of SPBC557.02c expression:

• Western blot quantification protocol:

  • Use a dilution series of recombinant SPBC557.02c protein to generate a standard curve

  • Include at least three biological replicates and two technical replicates

  • Normalize to a stable housekeeping protein (e.g., α-tubulin)

  • Use digital image analysis software with background subtraction

  • Apply statistical analysis to determine significance of expression changes

• ELISA-based quantification approach:

  • Develop a sandwich ELISA using the SPBC557.02c antibody as capture or detection antibody

  • Generate a standard curve with purified recombinant protein

  • Optimize blocking conditions to minimize background signal

  • Analyze data using four-parameter logistic regression

Both methods provide complementary data on protein abundance, with Western blotting offering information about protein size and potential post-translational modifications, while ELISA typically provides greater sensitivity for low-abundance proteins.

How should researchers interpret potential SPBC557.02c antibody cross-reactivity with other proteins?

Interpreting potential cross-reactivity requires systematic analysis:

• In silico prediction: Analyze sequence homology between SPBC557.02c and related proteins using bioinformatic tools to identify regions of similarity that might lead to cross-reactivity.

• Experimental verification:

  • Test antibody reactivity against recombinant proteins with similar domains

  • Use lysates from strains overexpressing potential cross-reactive proteins

  • Compare banding patterns with predicted molecular weights

• Epitope mapping:

  • Use peptide arrays or truncated protein constructs to identify the specific epitope(s) recognized

  • Analyze these epitopes for conservation across related proteins

• Data interpretation framework:

  • Unexpected bands at molecular weights different from SPBC557.02c require verification

  • Consider post-translational modifications that might alter migration patterns

  • Document all observed cross-reactivity in your experimental records and publications

This systematic approach helps distinguish true biological findings from technical artifacts, enhancing research reproducibility.

What are the optimal parameters for using SPBC557.02c antibody in immunofluorescence applications?

While the SPBC557.02c antibody product sheet specifically mentions ELISA and Western blot applications , researchers may wish to explore immunofluorescence applications. A systematic optimization approach includes:

Document all optimization steps systematically to establish a reproducible protocol. Include appropriate controls, such as cells not expressing SPBC557.02c, to confirm signal specificity.

How can researchers troubleshoot inconsistent Western blot results with SPBC557.02c antibody?

When encountering inconsistent Western blot results with SPBC557.02c antibody, implement this structured troubleshooting protocol:

• Sample preparation assessment:

  • Verify complete protein denaturation and reduction

  • Test different lysis buffers to optimize protein extraction

  • Add protease inhibitors to prevent degradation

  • Ensure consistent protein quantification across samples

• Electrophoresis parameter optimization:

  • Adjust polyacrylamide percentage based on SPBC557.02c molecular weight

  • Optimize running conditions (voltage, time)

  • Consider gradient gels for better resolution

• Transfer efficiency verification:

  • Test different membrane types (PVDF vs. nitrocellulose)

  • Optimize transfer time and voltage

  • Verify transfer using reversible protein stains

• Immunodetection parameter refinement:

  • Test different blocking agents (BSA vs. non-fat milk)

  • Optimize primary antibody concentration and incubation time

  • Evaluate different detection systems (chemiluminescence vs. fluorescence)

This systematic approach can identify the source of inconsistency and lead to a robust, reproducible protocol for SPBC557.02c detection.

What considerations are important for co-immunoprecipitation studies using SPBC557.02c antibody?

For successful co-immunoprecipitation studies to identify SPBC557.02c interaction partners:

• Lysis buffer optimization:

  • Test buffers with varying detergent strengths to preserve interactions

  • Consider mild detergents (0.1% NP-40 or Digitonin) for membrane proteins

  • Include stabilizing agents like glycerol (10%) to maintain protein complexes

  • Test different salt concentrations to optimize stringency

• Immunoprecipitation strategy selection:

  • Compare direct coupling of antibody to beads vs. protein A/G approaches

  • Test pre-clearing lysates to reduce non-specific binding

  • Optimize antibody-to-lysate ratios

• Controls implementation:

  • Include IgG isotype control immunoprecipitations

  • Use SPBC557.02c knockout strains as negative controls

  • Perform reverse immunoprecipitations with antibodies against suspected interactors

• Validation of interactions:

  • Confirm results with orthogonal methods (e.g., proximity ligation assay)

  • Test interaction dependency on experimental conditions

  • Verify biological relevance through functional studies

This comprehensive approach maximizes the likelihood of identifying genuine SPBC557.02c interaction partners while minimizing false positives.

How does terminology affect researchers' understanding of antibody test results and reliability?

Research on antibody terminology demonstrates significant impacts on researcher perception and behavior. A study published in medRxiv examined how terminology influences understanding of antibody test results, finding that describing tests as detecting "immunity" versus simply detecting "antibodies" significantly affected result interpretation .

Specifically, participants who saw immunity-focused terminology were more likely to incorrectly believe that positive results meant "no risk" of future infection (19.1%) compared to those who saw "antibody" terminology (9.8%) . This misconception could potentially lead to decreased adherence to laboratory safety protocols.

For SPBC557.02c antibody research, this has important implications:

• Researchers should maintain precise terminology when describing antibody-based detection results

• Laboratory reports should clearly communicate that antibody reactivity indicates protein presence, not absolute confirmation of protein function

• Interpretation guidelines should accompany experimental results to prevent overinterpretation

• Terminology standardization across research groups can improve result reproducibility and interpretation

This evidence underscores the importance of precise communication in antibody-based research to ensure accurate data interpretation.

How can researchers leverage structural antibody databases to enhance SPBC557.02c antibody applications?

The Structural Antibody Database (SAbDab) provides researchers with valuable resources for antibody engineering and application optimization . For SPBC557.02c antibody applications, researchers can:

• Analyze structural homology:

  • Compare SPBC557.02c antibody sequences with structurally characterized antibodies

  • Identify complementarity determining regions (CDRs) and predict their conformations

  • Use this information to understand epitope recognition mechanisms

• Optimize binding conditions:

  • Analyze variable domain orientations that maximize binding efficiency

  • Identify buffer conditions that promote optimal antibody conformation

  • Implement structural insights to improve immunoprecipitation protocols

• Engineer enhanced variants:

  • Use structural information to guide site-directed mutagenesis for improved affinity

  • Design recombinant antibody fragments with preserved binding properties

  • Develop bispecific antibodies for co-localization studies

The SAbDab database, which updates weekly and contained 1,624 antibody structures as of 2013 , continues to grow and provides an invaluable resource for advanced antibody applications in research settings.

What emerging technologies might enhance SPBC557.02c antibody applications in fission yeast research?

Several emerging technologies have potential to significantly advance SPBC557.02c antibody applications:

• CRISPR-engineered epitope tagging:

  • Endogenous tagging of SPBC557.02c with standardized epitopes

  • Creation of knock-in reporter systems for real-time visualization

  • Generation of conditional expression systems for functional studies

• Single-molecule imaging approaches:

  • Direct visualization of SPBC557.02c dynamics in living cells

  • Quantification of protein-protein interaction kinetics

  • Correlation with cellular phenotypes and responses

• Antibody engineering innovations:

  • Development of nanobodies or single-domain antibodies with enhanced penetration

  • Creation of intrabodies for live-cell applications

  • Production of bispecific antibodies for co-localization studies

These approaches represent the frontier of antibody-based research technologies and offer promising avenues for deeper understanding of SPBC557.02c function in fission yeast biology.